MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ZVSA has $1,040,260 in assets. $12,765,827 in debts.

Balance Sheets Overview

Current Ratio
7.80%
Debt to Asset Ratio
1227.18%
Assets Breakdown
    • Cash
    • Prepaid expenses and other curre...
    • Vendor deposits
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in-capital
    • Accounts payable
    • Others

Unit: Dollar
Balance Sheets
2025-09-30
2025-06-30
Cash
527,978 72,086
Prepaid expenses and other current assets
298,192 378,749
Vendor deposits
169,363 98,234
Total current assets
995,533 549,069
Vendor deposit
-69,477
In-process research and development
-18,647,903
Deferred offering costs
44,727 374,662
Total assets
1,040,260 19,641,111
Accounts payable
9,805,129 9,774,230
Accrued expenses and other current liabilities
2,960,698 2,915,448
Total current liabilities
12,765,827 12,689,678
Deferred tax liability
-851,659
Total liabilities
12,765,827 13,541,337
Preferred stock-Series BPreferred Stock
1 1
Preferred stock-Series APreferred Stock
-0
Common stock
809 487
Additional paid-in-capital
125,187,156 123,207,260
Accumulated deficit
-136,906,365 -117,100,806
Treasury stock, at cost, 7 shares at september 30, 2025 and december 31, 2024
7,168 7,168
Total stockholders (deficit) equity
-11,725,567 6,099,774
Total liabilities and stockholders (deficit) equity
1,040,260 19,641,111
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Vendor deposits$169,363 Prepaid expenses andother current assets$298,192 Cash$527,978 Deferred offering costs$44,727 Total current assets$995,533 Total assets$1,040,260 Treasury stock, at cost, 7shares at september 30,...$7,168 Accumulated deficit-$136,906,365 Total liabilities andstockholders (deficit)...$1,040,260 Total stockholders(deficit) equity-$11,725,567 Additionalpaid-in-capital$125,187,156 Common stock$809 Preferred stock-SeriesBPreferred Stock$1 Total liabilities$12,765,827 Total currentliabilities$12,765,827 Accrued expenses andother current...$2,960,698 Accounts payable$9,805,129

ZyVersa Therapeutics, Inc. (ZVSA)

ZyVersa Therapeutics, Inc. (ZVSA)